Evotec to Report Third Quarter 2008 Results On November 14, 2008 - MarketWatch
Evotec to Report Third Quarter 2008 Results On November 14, 2008 MarketWatch - ... NMDA receptor antagonist for the treatment of Alzheimer's disease and/or pain, and a P2X7 antagonist for the treatment of inflammatory diseases. ... |
Original post: Evotec to Report Third Quarter 2008 Results On November 14, 2008 - MarketWatch by ©2008 Google at alzheimers treatment - Google News
Blog tag: Alzheimers treatment
Technorati tag: Alzheimers treatment